መነሻ › ዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ › New York › New York City
በNew York City፣ NY ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ 21 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Icahn School of Medicine at Mount Sinai ( Site 0164), New York
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ተሳታዮችን በመፈለግ ላይደረጃ 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Columbia University, New York
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Memorial Sloan Kettering Cancer Center, New York
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of ARC-02 in B-cell NHL
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
DALY II USA/ MB-CART2019.1 for DLBCL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Memorial Sloan Kettering Cancer Center, New York
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Memorial Sloan Kettering Cancer Center, New York
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
- Memorial Sloan Kettering Cancer Center, New York
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
ተሳታዮችን በመፈለግ ላይ
- Columbia University, New York
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
ተሳታዮችን በመፈለግ ላይ
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Memorial Sloan Kettering Cancer Center, New York
በሌሎች ከተሞች ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ጥናቶች
- Baldwin Park, CA19 ጥናቶች
- Chicago, IL18 ጥናቶች
- Houston, TX17 ጥናቶች
- Los Angeles, CA17 ጥናቶች
- Milwaukee, WI16 ጥናቶች
- Boston, MA16 ጥናቶች
- Nashville, TN15 ጥናቶች
- Philadelphia, PA15 ጥናቶች
- Portland, OR15 ጥናቶች
- Durham, NC14 ጥናቶች
- Dallas, TX13 ጥናቶች
- Washington, DC12 ጥናቶች
በNew York City ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር136 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር121 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)109 ጥናቶች
- የፕሮስቴት ካንሰር103 ጥናቶች
- Metastatic Cancer93 ጥናቶች
- የኮሎሬክታል ካንሰር78 ጥናቶች
- የእንቁላል ካንሰር69 ጥናቶች
- የሳንባ ካንሰር60 ጥናቶች
- Multiple Myeloma60 ጥናቶች
- የፓንክሪያስ ካንሰር60 ጥናቶች
- የኤንዶሜትሪየም ካንሰር52 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ51 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።